The intuitive motivation for employing a sibling comparison design is to adjust for confounding that is constant within families. Such confounding can be caused by variables that otherwise might prove difficult to measure, for example factors relating to genetics, environment, and upbringing. Recent methodological investigations have shown that despite its intuitive appeal, the conventionally employed analysis does not relate to a well-defined causal target, even in the case of constant confounding. A main challenge is that the analysis will target the subpopulation of exposure discordant pairs. In the presence of an effect of the cosibling's exposure on the sibling's outcome, there is a second challenge, namely that the effect corresponds to an intervention that always exposes the cosibling to the opposite exposure from the sibling. We characterise the sibling comparison in terms of the cross-over design. Estimands of interest are discussed before using this characterisation to establish more natural conditions for targeting an appropriate causal parameter. We cast the above-mentioned challenges of the sibling comparison in terms of those facing the cross-over trialist: in order to target an appropriate estimand one must be able to argue the absence of a certain type of carry-over effect as well as absence of trial-by-treatment interaction, thus establishing that the former study design emulates the latter warts and all. We explore weighting to counter the effects of such interactions and to target other estimands. The weights rely on estimates of the unobserved confounding structure. Through simulations and an example analysis, we illustrate its potential usefulness to assess the validity of the assumptions of the matched analysis. We briefly discuss an extension of the weighting procedure to remove selection bias based on data from a population-level reference sample.
Oslo University Hospital（奥斯陆大学医院）；University of Oslo（奥斯陆大学）；Leiden University Medical Center（莱顿大学医学中心）；Leiden University（莱顿大学）；Erasmus Medical Center, University Medical Center Rotterdam（伊拉斯姆斯医学中心，鹿特丹大学医学中心）
